Courage Against Cancer highlights the transformative potential of combined genomic and microbiome testing in oncology. This approach uses emerging technologies and artificial intelligence to personalize treatment strategies, enhancing recovery. As evidence accumulates, patients will access insights that inform complementary therapies alongside traditional care, supporting informed decision-making in cancer treatment.
